| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |